Alzheimer's disease beyond the genomic era: nuclear magnetic resonance (NMR) spectroscopy-based metabolomics

Alzheimer's disease (AD) is a complex disease, with no definitive biomarkers available that allow clinical diagnosis; this represents a major problem for the advance of efficient drug discovery programs. A successful approach towards the understanding and treatment of AD should take into consid...

Descripción completa

Detalles Bibliográficos
Autores principales: Barba, Ignasi, Fernandez-Montesinos, Rafael, Garcia-Dorado, David, Pozo, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918063/
https://www.ncbi.nlm.nih.gov/pubmed/18554316
http://dx.doi.org/10.1111/j.1582-4934.2008.00385.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918063/
https://www.ncbi.nlm.nih.gov/pubmed/18554316
http://dx.doi.org/10.1111/j.1582-4934.2008.00385.x

Ejemplares similares